S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
NASDAQ:CPIX

Cumberland Pharmaceuticals (CPIX) Stock Price, News & Analysis

$1.55
-0.08 (-4.91%)
(As of 04/15/2024 ET)
Today's Range
$1.55
$1.64
50-Day Range
$1.55
$2.21
52-Week Range
$1.43
$2.36
Volume
2,876 shs
Average Volume
11,707 shs
Market Capitalization
$21.98 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
CPIX stock logo

About Cumberland Pharmaceuticals Stock (NASDAQ:CPIX)

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and duodenal ulcer disease; Vaprisol, an injection for treating euvolemic and hypervolemic hyponatremia; Sancuso, an injection for the treatment of chemotherapy treatment; and Vibativ, an injection for the treatment of certain serious bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections. It develops RediTrex injection for the treatment of active rheumatoid, juvenile idiopathic, and severe psoriatic arthritis, as well as disabling psoriasis. In addition, the company is developing ifetroban, a product candidate that is in phase II clinical trial for the treatment of aspirin-exacerbated respiratory disease, systemic sclerosis, and duchenne muscular dystrophy; and has completed phase II clinical trial for the treatment of hepatorenal syndrome and portal hypertension. Further, it develops a clinical program for the use of ifetroban to treat progressive fibrosing interstitial lung diseases. The company was incorporated in 1999 and is headquartered in Nashville, Tennessee.

CPIX Stock Price History

CPIX Stock News Headlines

Trump’s “Tax Free” Retirement Strategy
Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.
Trump’s “Tax Free” Retirement Strategy
Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.
Cumberland releases 2024 football schedule
See More Headlines
Receive CPIX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cumberland Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/05/2024
Today
4/15/2024
Next Earnings (Estimated)
5/14/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceuticals
Current Symbol
NASDAQ:CPIX
CUSIP
23077010
Employees
91
Year Founded
1999

Profitability

Net Income
$-6,280,000.00
Pretax Margin
-15.89%

Debt

Sales & Book Value

Annual Sales
$39.55 million
Cash Flow
$0.66 per share
Book Value
$1.96 per share

Miscellaneous

Free Float
8,038,000
Market Cap
$21.98 million
Optionable
Optionable
Beta
0.16

Social Links

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Key Executives

  • Mr. A. J. Kazimi MBA (Age 66)
    Founder, Chairman, President & CEO
    Comp: $952.53k
  • Mr. John Michael Hamm (Age 68)
    VP & CFO
    Comp: $258.38k
  • Mr. James Lowrance Herman (Age 69)
    Executive VP of National Accounts & Chief Compliance Officer
    Comp: $372.27k
  • Mr. Chris T. Bitterman (Age 59)
    Vice President of Sales & Marketing
    Comp: $290.87k
  • Mr. Todd M. Anthony (Age 63)
    Vice President of Organizational Development
    Comp: $304.94k
  • Ms. Jean W. Marstiller (Age 74)
    Senior VP of Administrative Services & Corporate Secretary
    Comp: $282.17k
  • Mr. Adam S. Mostafa (Age 43)
    Managing Director
  • Ms. Erin Smith Gull
    Senior Corporate Relations Associate

CPIX Stock Analysis - Frequently Asked Questions

How have CPIX shares performed in 2024?

Cumberland Pharmaceuticals' stock was trading at $1.7917 at the start of the year. Since then, CPIX shares have decreased by 13.5% and is now trading at $1.55.
View the best growth stocks for 2024 here
.

Are investors shorting Cumberland Pharmaceuticals?

Cumberland Pharmaceuticals saw a drop in short interest in March. As of March 31st, there was short interest totaling 17,000 shares, a drop of 16.7% from the March 15th total of 20,400 shares. Based on an average trading volume of 11,800 shares, the short-interest ratio is currently 1.4 days. Currently, 0.2% of the company's shares are sold short.
View Cumberland Pharmaceuticals' Short Interest
.

When is Cumberland Pharmaceuticals' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024.
View our CPIX earnings forecast
.

How were Cumberland Pharmaceuticals' earnings last quarter?

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) issued its quarterly earnings results on Tuesday, March, 5th. The specialty pharmaceutical company reported ($0.12) EPS for the quarter. The specialty pharmaceutical company had revenue of $9.35 million for the quarter. Cumberland Pharmaceuticals had a positive trailing twelve-month return on equity of 6.84% and a negative net margin of 15.87%.

What is A. J. Kazimi's approval rating as Cumberland Pharmaceuticals' CEO?

9 employees have rated Cumberland Pharmaceuticals Chief Executive Officer A. J. Kazimi on Glassdoor.com. A. J. Kazimi has an approval rating of 9% among the company's employees. This puts A. J. Kazimi in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Cumberland Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cumberland Pharmaceuticals investors own include Fulcrum Therapeutics (FULC), VIVUS (VVUS), CymaBay Therapeutics (CBAY), Sorrento Therapeutics (SRNE), SCYNEXIS (SCYX), VBI Vaccines (VBIV), Akero Therapeutics (AKRO), Cerecor (CERC), Xeris Biopharma (XERS).

How do I buy shares of Cumberland Pharmaceuticals?

Shares of CPIX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:CPIX) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners